David Mitchell
Impact in
- Oncology top 5%
- Bone health and treatments
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Papers in
- Hematology 14
- Hematopoietic Stem Cell Transplantation 7
- Co-authors
- Dennis R. Petersen (7 shared papers)Judith S. Sebolt–Leopold (2 shared papers)Patricia LoRusso (2 shared papers)Mark B. Meyer (2 shared papers)Mary Varterasian (2 shared papers)Román Herrera (2 shared papers)Alex A. Adjei (2 shared papers)Oliver W. Press (3 shared papers)
- Journals
- Blood (6 papers)Clinical and Translational Science (5 papers)Drug Metabolism and Disposition (3 papers)Journal of Clinical Oncology (3 papers)Pediatric Blood & Cancer (3 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
David Mitchell
79 papers receiving 2.7k citations
David Mitchell's Hit Papers
Peers
Comparison fields: 5 of 118
- Oncology 816
- Hematology 304
- Orthopedics and Sports Medicine 180
- Pathology and Forensic Medicine 362
- Nephrology 138
Countries citing papers authored by David Mitchell
This map shows the geographic impact of David Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Mitchell more than expected).
Fields of papers citing papers by David Mitchell
This network shows the impact of papers produced by David Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Mitchell. The network helps show where David Mitchell may publish in the future.
Co-authors
The 25 scholars most cited alongside David Mitchell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Multicenter Phase II Study of the Oral MEK Inhibitor, CI-1040, in Patients With Advanced Non-Small-Cell Lung, Breast, Colon, and Pancreatic Cancer Hit paper breakdown → | 2004 | 524 |
| 2 | 2005 | 335 | |
| 3 | 1999 | 242 | |
| 4 | 2003 | 149 | |
| 5 | 1995 | 130 | |
| 6 | 1987 | 113 | |
| 7 | 1996 | 69 | |
| 8 | 2012 | 66 | |
| 9 | 2001 | 64 | |
| 10 | 2014 | 62 | |
| 11 | 2006 | 54 | |
| 12 | 1989 | 54 | |
| 13 | 2000 | 51 | |
| 14 | 1991 | 50 | |
| 15 | 1988 | 45 | |
| 16 | 2000 | 41 | |
| 17 | 1998 | 35 | |
| 18 | 2013 | 34 | |
| 19 | 2011 | 34 | |
| 20 | 2016 | 32 |
About David Mitchell
David Mitchell is a scholar working on Molecular Biology, Hematology, Oncology, Immunology and Pulmonary and Respiratory Medicine, having authored 81 papers that have together received 2.8k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (7 papers), Neutropenia and Cancer Infections (6 papers), Eicosanoids and Hypertension Pharmacology (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Immunodeficiency and Autoimmune Disorders (5 papers), Bone health and treatments (5 papers), Alcohol Consumption and Health Effects (5 papers) and Chronic Lymphocytic Leukemia Research (5 papers). The work is most often cited by research in Oncology (816 citations), Hematology (304 citations), Orthopedics and Sports Medicine (180 citations), Pathology and Forensic Medicine (362 citations) and Nephrology (138 citations). David Mitchell has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Dennis R. Petersen, Judith S. Sebolt–Leopold, Patricia LoRusso, Mark B. Meyer, Mary Varterasian, Román Herrera, Alex A. Adjei, Oliver W. Press, Oday Hamid and John J. Rinehart. Their work appears in journals such as Blood, Clinical and Translational Science, Drug Metabolism and Disposition, Journal of Clinical Oncology and Pediatric Blood & Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.